Han-Chi Fang

Title: Han-Chi Fang: Innovator in Serotype Identification

Introduction

Han-Chi Fang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of molecular biology, particularly in the identification of serotypes using advanced techniques.

Latest Patents

Han-Chi Fang holds a patent related to a method of identifying a serotype, specifically utilizing polymerase chain reaction (PCR) primer sets. This innovative method is designed according to a fragment of a capsular polysaccharide synthesis (cps) region to identify a K57 or a NTUH-N1 serotype. The NTUH-N1 serotype is a novel discovery that differs from the previously reported 77 serotypes. His PCR-based cps genotyping method addresses the issues of insufficient specificity and sensitivity found in conventional immune methods. This method can be applied in clinical diagnosis, offering advantages such as rapidity and low cost. Additionally, it reduces the rate of unidentifiable strains.

Career Highlights

Han-Chi Fang is affiliated with National Taiwan University, where he continues to advance research in his field. His work has garnered attention for its practical applications in clinical settings.

Collaborations

He has collaborated with notable colleagues, including Tzu-Lung Lin and Feng-Chiao Tsai, contributing to the advancement of research in serotype identification.

Conclusion

Han-Chi Fang's innovative approach to serotype identification through PCR technology represents a significant advancement in molecular diagnostics. His contributions are poised to enhance clinical practices and improve patient outcomes.